Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: Biochemical, pharmacological and toxicological aspects

International Journal of Biochemistry and Cell Biology

Volumn 28, Issue 3, 1996, Pages 259-274

  Lyles, G A ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

amine oxidase inhibitors; aromatic and aliphatic amine metabolism; blood plasma; cytotoxicity; semicarbazide sensitive amine oxidase; vascular smooth muscle

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING);

ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME SPECIFICITY; HUMAN; MEMBRANE BINDING; NONHUMAN; REVIEW; SMOOTH MUSCLE FIBER; TISSUE SPECIFICITY;

ANIMALIA; MAMMALIA;

EID: 0029869337     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/1357-2725(95)00130-1     Document Type: Review

References (113)

1. Andree T. H. and Clarke D. E. (1982a) Characteristics and specificity of phenelzine and benserazide as inhibitors of benzylamine oxidase and monoamine oxidase. Biochem. Pharmacol. 31, 825-830.
2. Andree T. H. and Clarke D. E. (1982b) Characteristics of rat skull benzylamine oxidase. Proc. Soc. Exp. Biol. Med. 171, 298-305.
3. Arai Y., Toyoshirna Y. and Kinemuchi H. (1986) Studies of monoamine oxidase and semicarbazide-sensitive amine oxidase. II. Inhibition by α-methylated substrate-analogue monoamines, α-methyltryptamine, α-methylbenzylamine and two enantiomers of α-methylbenzylamine. Jap. J. Pharmacol. 41, 191-197.
4. Banchelli G., Buffoni F., Elliott J. and Callingham B. A. (1990) A study of the biochemical pharmacology of 3,5-ethoxy-4-aminomethylpyridine (B24), a novel amine oxidase inhibitor with selectivity for tissue-bound semicarbazide-sensitive amine oxidase enzymes. Neurochem. Int. 17, 215-221.
5. Barker R., Boden N., Cayley G., Charlton S. C., Henson R., Holmes M. C., Kelly I. D. and Knowles P. F. (1979) Properties of cupric ions in benzylamine oxidase from pig plasma as studied by magnetic-resonance and kinetic methods. Biochem. J. 177, 289-302.
6. Barrand M. A. and Callingham B. A. (1982) Monoamine oxidase activities in brown adipose tissue of the rat: some properties and subcellular distribution. Biochem. Pharmacol. 31, 2177-2184.
7. Barrand M. A. and Callingham B. A. (1984) Solubilization and some properties of a semicarbazide-sensitive amine oxidase in brown adipose tissue of the rat. Biochem. J. 222, 467-475.
8. Barrand M. A. and Callingham B. A. (1985) The interaction of hydralazine with a semicarbazide-sensitive amine oxidase in brown adipose tissue of the rat. Biochem. J. 232, 415-423.
9. Barrand M. A., Fox S. A. and Callingham B. A. (1984) Amine oxidase activities in brown adipose tissue of the rat: identification of semicarbazide-sensitive (clorgyline-resistant) activity at the fat cell membrane. J. Pharm. Pharmacol. 38, 288-293.
10. Blaschko H. F. (1962) The amine oxidases of mammalian blood plasma. Adv. Comp. Physiol. Biochem. 1, 67-116.
11. Blicharski J. R. D. and Lyles G. A. (1990) Semicarbazide-sensitive amine oxidase activity in rat aortic cultured smooth muscle cells. J. Neural Transm. [Suppl.] 32, 337-339.
12. Blicharski J. R. D. and Lyles G. A. (1991) D,L-Buthionine sulphoximine, a glutathione-depleting agent, potentiates allylamine-induced cytotoxicity in rat aortic smooth muscle cultures. Br. J. Pharmacol. 102, 184P.
13. Boor P. J., Hysmith R. M. and Sanduja R. (1990) A role for a new vascular enzyme in the metabolism of xenobiotic amines. Circ. Res. 66, 249-252.
14. Boor P. J., Sanduja R., Nelson T. J. and Ansari G. A. S. (1987) In vivo metabolism of the cardiovascular toxin, allylamine. Biochem. Pharmacol. 36, 4347-4353.
15. Buffoni F. (1980) Some contributions to the problem of amine oxidase. Pharmacol. Res. Commun. 12, 101-114.
16. Buffoni F. (1990) Nature of the organic cofactor of pig plasma benzylamine oxidase. Biochim. Biophys. Acta 1040, 77-83.
17. Buffoni F., Banchelli G., Bertocci B. and Raimondi L. (1989) Effect of pyridoxamine on semicarbazide-sensitive amine oxidase activity of rabbit lung and heart. J. Pharm. Pharmacol. 41, 469-473.
18. Buffoni F., Banchelli G., Dolara P., Ignesti G., Pirisino R., Raimondi L. and Ziche M. (1985) Pyridoxamine as inhibitor of the blood plasma benzylamine oxidase and other copper-containing amine oxidases. J. Pharm. Pharmacol. 37, 597-600.
19. Buffoni F., Della Corte L. and Hope D. B. (1977) Immuno-fluorescence histochemistry of porcine tissues using antibodies to pig plasma amine oxidase. Proc. R. Soc. Lond. (Biol). 195, 417-423.
20. Cao Danh H., Strolin Benedetti M., Dostert P. and Mousset A. (1984) Age-related changes in benzylamine oxidase activity in rat tissues. J. Pharm. Pharmacol. 36, 592-596.
21. Clarke D. E., Lyles G. A. and Callingham B. A. (1982) A comparison of cardiac and vascular clorgyline-resistant amine oxidase and monoamine oxidase. Biochem. Pharmacol. 31, 27-35.
22. Collison D., Knowles P. F., Mabbs F. E., Rius F. X., Singh I., Dooley D. M., Cote C. E. and McGuirl M. (1989) Studies on the active site of pig plasma amine oxidase. Biochem. J. 264, 663-669.
23. Coquil J. F., Goridis C., Mack G. and Neff N. H. (1973) Monoamine oxidase in rat arteries: evidence for different forms and selective localization. Br. J. Pharmacol. 148, 590-599.
24. Dostert P. (1994) Can our knowledge of monoamine oxidase (MAO) help in the design of better MAO inhibitors? J. Neural Transm. [Suppl.] 41, 269-279.
25. Dostert P., Guffroy C., Strolin Benedetti M. and Boucher T. (1984) Inhibition of semicarbazide-sensitive amine oxidase by monoamine oxidase inhibitors from the oxazolidinone series. J. Pharm. Pharmacol. 36, 782-785.
26. Elliott J., Callingham B. A. and Barrand M. A. (1989a) In vivo effects of (E)-2-(3′,4′-dimethoxyphenyl)3-fluoroallylamine (MDL 72145) on amine oxidase activities in the rat. Selective inhibition of semicarbazide-sensitive amine oxidase in vascular and brown adipose tissues. J. Pharm. Pharmacol. 41, 37-41.
27. Elliott J., Callingham B. A. and Sharman D. F. (1989b) Metabolism of amines in the isolated perfused mesenteric arterial bed of the rat. Br. J. Pharmacol. 98, 507-514.
28. Elliott J., Callingham B. A. and Sharman D. F. (1989c) The influence of amine metabolizing enzymes on the pharmacology of tyramine in the isolated perfused mesenteric arterial bed of the rat. Br. J. Pharmacol. 98, 515-522.
29. Elliott J., Fowden A. L., Callingham B. A., Sharman D. F. and Silver M. (1991) Physiological and pathological influences on sheep blood plasma amine oxidase: effect of pregnancy and experimental alloxan-induced diabetes mellitus. Res. Vet. Sci. 50, 334-339.
30. Eriksson M. and Fowler C. J. (1984) Inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by mexiletine and related compounds. Naunyn Schmiedebergs Arch. Pharmacol. 327, 273-278.
31. Fowler C. J., Eriksson M., Thorell G. and Magnusson O. (1984) Stereoselective inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by 4-dimethylamino-2,α-dimethylphenethylamine (FLA 336). Naunyn Schmiedebergs Arch. Pharmacol. 327, 279-284.
32. Gorkin V. Z. (1983) Amine Oxidases in Clinical Research. Pergamon Press, Oxford.
33. Guffroy C., Boucher T. and Strolin Benedetti M. (1985) Further investigations of the metabolism of two trace amines, β-phenylethylamine and p-tyramine by rat aorta semicarbazide-sensitive amine oxidase. In Neuropharmacology of the Trace Amines (Edited by Boulton A. A., Maitre L. L., Bieck P. R. and Riederer P.), pp. 39-50. Humana Press, Clifton, N.J.
34. Guffroy C. and Strolin Benedetti M. (1984) Monoamine oxidase and semicarbazide-sensitive amine oxidase in spontaneously hypertensive and in normotensive control rats. Life Sci. 34, 535-545.
35. Harris E. D. and O'Dell B. L. (1972) Comparison of soluble and particulate amine oxidases from bovine aorta. Biochem. Biophys. Res. Commun. 48, 1173-1178.
36. Hayes B. E. and Clarke D. E. (1985) Benzylamine oxidase activity in spontaneously hypertensive rats. Res. Commun. Chem. Pathol. Pharmacol. 47, 137-140.
37. Hayes B. E. and Clarke D. E. (1990) Semicarbazide-sensitive amine oxidase activity in streptozotocin diabetic rats. Res. Commun. Chem. Pathol. Pharmacol. 69, 71-83.
38. Holt A. and Callingham B. A. (1994a) The ex vivo effects of procarbazine and methylhydrazine on some rat amine oxidase activities. J. Neural Transm. [Suppl.] 41, 439-443.
39. Holt A. and Callingham B. A. (1994b) Location of the active site of rat vascular semicarbazide-sensitive amine oxidase. J. Neural Transm. [Suppl.] 41, 433-437.
40. Houslay M. D. and Tipton K. F. (1975) Inhibition of beef plasma amine oxidase by clorgyline. Biochem. Pharmacol. 24, 429-431.
41. Hysmith R. M. and Boor P. J. (1987) In vitro expression of benzylamine oxidase activity in cultured porcine smooth muscle cells. J. Cardiovasc. Pharmacol. 9, 668-674.
42. Hysmith R. M. and Boor P. J. (1988a) Purification of benzylamine oxidase from cultured porcine aortic smooth muscle cells. Biochem. Cell. Biol. 66, 821-829.
43. Hysmith R. M. and Boor P. J. (1988b) Role of benzylamine oxidase in the cytotoxicity of allylamine toward aortic smooth muscle cells. Toxicology 51, 133-145.
44. Ishizaki F. (1990) Plasma benzylamine oxidase activity in cerebrovascular disease. Eur. Neurol. 30, 104-107.
45. Janes S. M. and Klinman J. P. (1991) An investigation of bovine serum amine oxidase active site stoichiometry: evidence for an aminotransferase mechanism involving two carbonyl cofactors per enzyme dimer. Biochemistry 30, 4599-4605.
46. Janes S. M., Mu D., Wemmer D., Smith A. J., Kaur S., Maltby D., Burlingame A. L. and Klinman J. P. (1990) A new redox cofactor in eukaryotic enzymes: 6-hydroxydopa at the active site of bovine serum amine oxidase. Science 248, 981-987.
47. Janes S. M., Palcic M. M., Scaman C. H., Smith A. J., Brown D. E., Dooley D. M., Mure M. and Klinman J. P. (1992) Identification of topaquinone and its consensus sequence in copper amine oxidases. Biochemistry 31, 12147-12154.
48. Johnson T. D., Takebayashi D. T., Forster R. M. and Clarke D. E. (1986) Monoamine oxidase inhibition but not inhibition of semicarbazide-sensitive amine oxidase potentiates tryptamine responses in the human umbilical artery: a comparison with 5-hydroxytryptamine. Proc. West. Pharmacol. Soc. 29, 109-112.
49. Kagan H. M. and Trackman P. C. (1991) Properties and function of lysyl oxidase. Am. J. Respir. Cell Molec. Biol. 5, 206-210.
50. Knowles P. F., Strange R. W., Blackburn N. J. and Hasnain S. S. (1989) EXAFS studies on pig plasma amine oxidase. A detailed structural analysis using the curved wave multiple scattering approach. J. Am. Chem. Soc. 111, 102-107.
51. Kumazawa T., Seno, H., Urakami T. and Suzuki O. (1990) Failure to verify the presence of pyrroloquinoline quinone (PQQ) in bovine plasma amine oxidase by gas chromatography/mass spectrometry. Arch. Biochem. Biophys. 283, 533-536.
52. Lewinsohn R. (1981) Amine oxidase in human blood vessels and non-vascular smooth muscle. J. Pharm. Pharmacol. 33, 569-575.
53. Lewinsohn R. (1984) Mammalian monoamine-oxidizing enzymes, with special reference to benzylamine oxidase in human tissues. Braz. J. Med. Biol. Res. 17, 223-256.
54. Lewinsohn R., Bohm K.-H., Glover V. and Sandler M. (1978) A benzylamine oxidase distinct from monoamine oxidase B - widespread distribution in man and rat. Biochem. Pharmacol. 27, 1857-1863.
55. Lewinsohn R., Glover V. and Sandler M. (1980) β-phenylethylamine and benzylamine as substrates for human monoamine oxidase A: a source of some anomalies. Biochem. Pharmacol. 29, 777-781.
56. Lizcano J. M., Balsa D., Tipton K. F. and Unzeta M. (1990) Amine oxidase activities in bovine lung. J. Neural Transm. [Suppl] 32, 341-344.
57. Lizcano J. M., Balsa D., Tipton K. F. and Unzeta M. (1991a) The oxidation of dopamine by the semicarbazide-sensitive amine oxidase (SSAO) from rat vas deferens. Biochem. Pharmacol. 41, 1107-1110.
58. Lizcano J. M., Escrich E., Ribalta T., Muntane J. and Unzeta M. (1991b) Amine oxidase activities in rat breast cancer induced experimentally with 7,12-dimethylbenz(α)anthracene. Biochem. Pharmacol. 42, 263-269.
59. Lizcano J. M., Fernandez de Arriba A., Lyles G. A. and Unzeta M. (1994) Several aspects on the amine oxidation by semicarbazide-sensitive amine oxidase (SSAO) from bovine lung. J. Neural Transm. [Suppl.] 41, 415-420.
60. Lobenstein-Verbeek C. L., Jongejan J. A., Frank J. and Duine J. A. (1984) Bovine serum amine oxidase: a mammalian enzyme having covalently bound PQQ as prosthetic group. FEBS Lett. 170, 305-309.
61. Lyles G. A. (1984) The interaction of semicarbazide-sensitive amine oxidase with MAO inhibitors. In: Monoamine Oxidase and Disease (Edited by Tipton K. F., Dostert P. and Strolin Benedetti M.), pp. 547-556. Academic Press, London.
62. Lyles G. A. and Bertie K. H. (1987) Properties of a semicarbazide-sensitive amine oxidase in rat articular cartilage. Pharmacol. Toxicol. (Suppl. 1) 60, 33.
63. Lyles G. A. and Callingham B. A. (1975) Evidence for a clorgyline-resistant monoamine metabolizing activity in the rat heart. J. Pharm. Pharmacol. 27, 682-691.
64. Lyles G. A. and Callingham B. A. (1982) In vitro and in vivo inhibition by benserazide of clorgyline-resistant amine oxidases in rat cardiovascular tissues. Biochem. Pharmacol. 31, 1417-1424.
65. Lyles G. A. and Chalmers J. (1992) The metabolism of aminoacetone to methylglyoxal by semicarbazide-sensitive amine oxidase in human umbilical artery. Biochem. Pharmacol. 43, 1409-1414.
66. Lyles G. A. and Chalmers J. (1995) Aminoacetone metabolism by semicarbazide-sensitive amine oxidase in human umbilical artery. Biochem. Pharmacol. 49, 416-419.
67. Lyles G. A. and Fitzpatrick C. M. S. (1984) A comparison of some carbonyl reagents as inhibitors of rat aorta semicarbazide-sensitive amine oxidase. J. Pharm. Pharmacol. (Workshop Suppl.) 36, 24W.
68. Lyles G. A., Garcia-Rodriguez J. and Callingham B. A. (1983) Inhibitory actions of hydralazine upon monoamine oxidizing enzymes in the rat. Biochem. Pharmacol. 32, 2515-2521.
69. Lyles G. A., Holt A. and Marshall C. M. S. (1990) Further studies on the metabolism of methylamine by semicarbazide-sensitive amine oxidase activities in human plasma, umbilical artery and rat aorta. J. Pharm. Pharmacol. 42, 332-338.
70. Lyles G. A., Marshall C. M. S. and Flucker C. J. R. (1989) Comparative ex vivo inhibitory effects of (E)-2-(3,4-dimethoxyphenyl)-3-fluoroallylamine (MDL 72145) on amine oxidase activities in the rat. Biochem. Pharmacol. 38, 2937-2940.
71. Lyles G. A., Marshall C. M. S., McDonald I. A., Bey P. and Palfreyman M. G. (1987) Inhibition of rat aorta semicarbazide-sensitive amine oxidase by 2-phenyl-3-haloallylamines and related compounds. Biochem. Pharmacol. 36, 2847-2853.
72. Lyles G. A. and McDougall S. A. (1989) The enhanced daily excretion of urinary methylamine in rats treated with semicarbazide or hydralazine may be related to the inhibition of semicarbazide-sensitive amine oxidase. J. Pharm. Pharmacol. 41, 97-100.
73. Lyles G. A. and Singh I. (1985) Vascular smooth muscle cells: a major source of the semicarbazide-sensitive amine oxidase of the rat aorta. J. Pharm. Pharmacol. 37, 637-643.
74. Lyles G. A. and Taneja D. T. (1987) Effects of amine oxidase inhibitors upon tryptamine metabolism and tryptamine-induced contraction of rat aorta. Br. J. Pharmacol. 90, 16P.
75. McCracken J., Peisach J. and Dooley D. M. (1987) Cu (II) coordination chemistry of amine oxidases: pulsed EPR studies of histidine imidazole, water, and exogenous ligand coordination. J. Am. Chem. Soc. 109, 4064-4072.
76. McEwen C. M. (1965) Human plasma monoamine oxidase. J. Biol. Chem. 240, 2003-2010.
77. Mehrabian Z. B. and Nalbandyan R. M. (1983) Benzylamine oxidase from brain microvessels. FEBS Lett. 164, 89-92.
78. Morgan D. M. L. (1985) Polyamine oxidases. Biochem. Soc. Trans. 13, 322-326.
79. Morpurgo L., Agostinelli E., Befani O. and Mondovi B. (1987) Reactions of bovine serum amine oxidase with NN-diethyldithiocarbamate. Biochem. J. 248, 865-870.
80. Morikawa F., Ueda T., Arai Y. and Kinemuchi H. (1986) Inhibition of monoamine oxidase A-form and semicarbazide-sensitive amine oxidase by selective and reversible monoamine oxidase-A inhibitors, amiflamine and FLA 788(+). Pharmacology 32, 38-45.
81. Mu D., Medzihradszky K. F., Adams G. W., Mayer P., Hines W. M., Burlingame A. L., Smith A. J., Cai D. and Klinman J. P. (1994) Primary structures for a mammalian cellular and serum copper amine oxidase. J. Biol. Chem. 269, 9926-9932.
82. Murphy D. L., Sims K. B., Karoum F., Garrick N. A., de la Chapelle A., Sankila E. M., Norio R. and Breakefield X. O. (1991) Plasma amine oxidase activities in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase. J. Neural Transm. [Gen Sect] 83, 1-12.
83. Nakano G., Harada M. and Nagatsu T. (1974) Purification and properties of an amine oxidase in bovine dental pulp and its comparison with serum amine oxidase. Biochim. Biophys. Acta 341, 366-377.
84. Norqvist A., Fowler C. J. and Oreland L. (1981) The deamination of monoamines by pig dental pulp. Biochem. Pharmacol. 30, 403-409.
85. Norqvist A and Oreland L. (1989) Localization of a semicarbazide-sensitive serotonin-oxidizing enzyme from porcine dental pulp. Biogenic Amines 6, 65-74.
86. Oratore A., Banchelli G., Buffoni F., Sabatini S., Mondovi B. and Finazzi-Agro A. (1981) Reaction between mammalian amine oxidases and their antibodies. Biochem. Biophys. Res. Commun. 98, 1002-1007.
87. Parchment R. E., Lewellyn A., Swartzendruber D. and Pierce E. L. (1990) Serum amine oxidase contributes to crisis in mouse embryo cell lines. Proc. Natl. Acad. Sci. U.S.A. 87, 4340-4344.
88. Precious E., Gunn C. E. and Lyles G. A. (1988) Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rat aorta. Biochem. Pharmacol. 37, 707-713.
89. Precious E. and Lyles G. A. (1988) Properties of a semicarbazide-sensitive amine oxidase in human umbilical artery. J. Pharm. Pharmacol. 40, 627-633.
90. Raimondi L., Banchelli G., Bertocci B., Lodovici M., Ignesti G., Pirisino R., Buffoni F., Bertini V. and De Munno A. (1985) Reaction of pig plasma benzylamine oxidase with beta-aminoproprionitrile. Agents Actions 16, 95-98.
91. Raimondi L., Conforti L., Ignesti G., Pirisino R. and Buffoni F. (1993) Histamine lipolytic activity and semicarbazide-sensitive amine oxidase (SSAO) of rat white adipose tissue (WAT). Biochem. Pharmacol. 46, 1369-1376.
92. Raimondi L., Pirisino R., Ignesti G., Capecchi S., Banchelli G. and Buffoni F. (1991) Semicarbazide-sensitive amine oxidase activity (SSAO) of rat epididymal white adipose tissue. Biochem. Pharmacol. 41, 467-470.
93. Ramos K., Grossman S. L. and Cox L. R. (1988) Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors. Toxicol. Appl. Pharmacol. 95, 61-71.
94. Rando R. R. and de Mairena J. (1974) Propargyl amine-induced irreversible inhibition of non-flavin-linked amine oxidases. Biochem. Pharmacol. 23, 463-467.
95. Ray S. and Ray M. (1983) Formation of methylglyoxal from aminoacetone by goat plasma. J. biol. Chem. 258, 3461-3462.
96. Roth J. A. and Gillis C. N. (1975) Multiple forms of amine oxidase in perfused rabbit lung. J. Pharmacol. exp. Ther. 194, 537-544.
97. Rucker R. B. and Goettlich-Riemann W. (1972) Properties of rabbit aorta amine oxidases. Proc. Soc. exp. Biol. Med. 139, 286-289.
98. Rucker R. B. and O'Dell B. L. (1971) Connective tissue amine oxidase. I. Purification of bovine aorta amine oxidase and its comparison with plasma amine oxidase. Biochim. Biophys. Acta. 235, 32-43.
99. Sharman D. F., Kelly M. J. and Loncar-Stevanovic H. (1983) The metabolism of dopamine in the blood of ruminant animals: an enzyme system to metabolize dopamine released from the mast cells in these species? Comp. Biochem. Physiol. 75C, 217-222.
100. Shieh J. J., Tamaye R. and Yasunobu K. T. (1975) A purification procedure for the study of homogeneous preparations of bovine aorta amine oxidase and a study of its lysyl oxidase activity. Biochim. biophys. Acta 377, 229-238.
101. Strolin Benedetti M. and Dostert P. (1985) Stereochemical aspects of MAO interactions: reversible and selective inhibitors of monoamine oxidase. Trends Pharmacol. Sci. 6, 246-251.
102. Suzuki O. and Matsumoto T. (1987) Properties of benzylamine oxidase in human small intestine. Biogenic Amines 4, 45-53.
103. Taneja D. T. and Lyles G. A. (1988) Use of an oil immersion technique to study the role of amine oxidase inhibition in potentiating tryptamine-induced contractions of rat aorta. Pharmacol. Res. Commun. 20 (Suppl. 4), 127-128.
104. Tang S.-S., Chichester C. O. and Kagan H. M. (1989) Comparative sensitivities of purified preparations of lysyl oxidase and other amine oxidases to active site-directed enzyme inhibitors. Connective Tiss. Res. 19, 93-103.
105. Trevethick M. A., Olverman H. J., Pearson J. D., Gordon J. L., Lyles G. A. and Callingham B. A. (1981) Monoamine oxidase activities of porcine vascular endothelial and smooth muscle cells. Biochem. Pharmacol. 30, 2209-2216.
106. Tryding N., Nilsson S. E., Tufvesson G., Berg R., Carlstrom S., Elmfors B. and Nilsson J. E. (1969) Physiological and pathological influences on serum monoamine oxidase level. Scand. J. clin. Lab. Invest. 23, 79-84.
107. Turini P., Sabatini S., Befani O., Chimenti F., Casanova C., Riccio P. L. and Mondovi B. (1982) Purification of bovine plasma amine oxidase. Analyt. Biochem. 125, 294-298.
108. Wibo M., Duong A. T. and Godfraind T. (1980) Subcellular location of semicarbazide-sensitive amine oxidase in rat aorta. Eur. J. Biochem. 112, 87-94.
109. Yu P. H. (1988) Three types of stereospecificity and the kinetic deuterium isotope effect in the oxidative deamination of dopamine as catalyzed by different amine oxidases. Biochem. Cell. Biol. 66, 853-861.
110. Yu P. H. (1990) Oxidative deamination of aliphatic amines by rat aorta semicarbazide-sensitive amine oxidase. J. Pharm. Pharmacol. 42, 882-884.
111. Yu P. H. and Zuo D.-M. (1993) Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Diabetes 42, 594-603.
112. Yu P. H., Zuo, D.-M. and Davis B. A. (1994) Characterization of human serum and umbilical artery semicarbazide-sensitive amine oxidase (SSAO). Biochem. Pharmacol. 47, 1055-1059.
113. Yuen C.-T., Easton D., Misch K. J. and Rhodes E. L. (1987) Increased activity of serum amine oxidase in granuloma annulare, necrobiosis lipoidica and diabetes. Br. J. Dermatol. 116, 643-649.